Position in PFE
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$101,136
-$38,927 QoQ
Shares Held
4,200
-15.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,543
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Jun 30, 2021CallValue
$3,916
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOTH FINANCIAL ADVISORY CORP holds $48,675,880 across 11 Drug Manufacturers - General names. PFE ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
63,494 | $16,125,571 | |
| 2 | ABBV |
AbbVie Inc.
|
59,705 | $15,024,166 | |
| 3 | AMGN |
Amgen Inc
|
28,421 | $10,291,812 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
97,037 | $5,591,271 | |
| 5 | LLY |
ELI LILLY & Co
|
1,207 | $1,447,712 | |
| 6 | PFE |
Pfizer Inc
This page
|
4,200 | $101,136 | |
| 7 | MRK |
Merck & Co., Inc.
|
539 | $69,261 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
117 | $14,781 |
All Filings in PFE
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101,136 | 4,200 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $140,063 | 4,988 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $35,084 | 1,409 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $35,672 | 1,400 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $53,158 | 2,193 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $75,741 | 2,989 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $71,577 | 2,698 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $77,848 | 2,690 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $104,029 | 3,718 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $102,980 | 3,711 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $111,388 | 3,869 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $128,168 | 3,864 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $177,494 | 4,839 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $168,504 | 4,130 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $227,915 | 4,448 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $201,558 | 4,606 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $232,422 | 4,433 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $231,101 | 4,464 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $259,052 | 4,387 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $188,383 | 4,380 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $171,207 | 4,372 | Shares | Sole | 2021-07-26 | |
| 2021-06-30 | $3,916 | 100 | Call | Sole | 2021-07-26 | |
| 2021-03-31 | $159,556 | 4,404 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $161,743 | 4,394 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $159,534 | 4,347 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $119,158 | 3,644 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $6,527 | 200 | Call | Sole | 2020-04-20 | |
| 2020-03-31 | $92,371 | 2,830 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||